X-linked myopathy with postural muscle atrophy: genes and variants
Explore variant evidence for X-linked myopathy with postural muscle atrophy across 1 analyzed protein (FHL1). Linked ClinVar records include 17 pathogenic or likely pathogenic variants, 106 variants of uncertain significance and 9 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to X-linked myopathy with postural muscle atrophy
FHL1: Four and a half LIM domains protein 1
It organizes protein complexes in striated muscle and participates in mechanosensing, sarcomere structure, and transcriptional responses. X-linked pathogenic variants cause a spectrum including reducing-body myopathy, Emery-Dreifuss muscular dystrophy, scapuloperoneal myopathy, and cardiomyopathy.
17 ClinVar pathogenic / likely pathogenic and 115 uncertain variants in FHL1 have source records linked to X-linked myopathy with postural muscle atrophy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to X-linked myopathy with postural muscle atrophy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FHL1 C150R | 150 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★★) |
| FHL1 C153R | 153 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★★) |
| FHL1 W122S | 122 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★★) |
| FHL1 C224W | 224 | Pathogenic / likely pathogenic (★★) | |
| FHL1 H123R | 123 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 H123Q | 123 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 C150Y | 150 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 C150W | 150 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 C153W | 153 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 C153S | 153 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 C153Y | 153 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 M1T | 1 | Pathogenic / likely pathogenic (★) | |
| FHL1 C101R | 101 | LIM zinc-binding 2 | Pathogenic / likely pathogenic (★) |
| FHL1 C209R | 209 | LIM zinc-binding 3 | Pathogenic / likely pathogenic (★) |
| FHL1 C276Y | 276 | Pathogenic / likely pathogenic (★) | |
| FHL1 T315S | 315 | Pathogenic / likely pathogenic (★) | |
| FHL1 V280M | 280 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in X-linked myopathy with postural muscle atrophy
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| FHL1 W122C | 122 | LIM zinc-binding 2 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; W122S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| FHL1 C153G | 153 | LIM zinc-binding 2 | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; C153W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
Same protein, different disease
- Myopathy, reducing body, X-linked, early-onset, severe also has ClinVar records linked to FHL1 variants; they fall in the same places as the X-linked myopathy with postural muscle atrophy variants (5 pathogenic / likely pathogenic).
Diseases related to X-linked myopathy with postural muscle atrophy
- Emery-Dreifuss muscular dystrophy, also linked to FHL1
- Myopathy, also linked to FHL1
- Myopathy, reducing body, X-linked, early-onset, severe, also linked to FHL1
- Centronuclear myopathy, also linked to FHL1
- Myopathy, reducing body, X-linked, childhood-onset, also linked to FHL1
Frequently asked questions
Which genes have records linked to X-linked myopathy with postural muscle atrophy?
This view contains 1 analyzed proteins: FHL1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 17 pathogenic or likely pathogenic variants, 106 variants of uncertain significance and 9 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 182 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center